Three-year corneal graft survival rate in high-risk cases treated with subconjunctival and topical bevacizumab
Crossref DOI link: https://doi.org/10.1007/s00417-014-2851-8
Published Online: 2014-11-16
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dekaris, Iva
Gabrić, Nikica
Drača, Nataša
Pauk-Gulić, Maja
Miličić, Neven
Text and Data Mining valid from 2014-11-16